PD-L1 and Immune Infiltration of m6A RNA Methylation Regulators and Its miRNA Regulators in Hepatocellular Carcinoma
Background. The aim of this study was to systematically evaluate the relationship between the expression of m6A RNA methylation regulators and prognosis in HCC. Methods. We compared the expression of m6A methylation modulators and PD-L1 between HCC and normal in TCGA database. HCC samples were divid...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2021/5516100 |
id |
doaj-faa20c13023f4181a8f2023ecf5b7ef0 |
---|---|
record_format |
Article |
spelling |
doaj-faa20c13023f4181a8f2023ecf5b7ef02021-05-31T00:33:00ZengHindawi LimitedBioMed Research International2314-61412021-01-01202110.1155/2021/5516100PD-L1 and Immune Infiltration of m6A RNA Methylation Regulators and Its miRNA Regulators in Hepatocellular CarcinomaYingxue Lin0Yinhui Yao1Ying Wang2Lingdi Wang3Haipeng Cui4Department of MedicineDepartment of MedicineDepartment of MedicineDepartment of MedicineDepartment of PathophysiologyBackground. The aim of this study was to systematically evaluate the relationship between the expression of m6A RNA methylation regulators and prognosis in HCC. Methods. We compared the expression of m6A methylation modulators and PD-L1 between HCC and normal in TCGA database. HCC samples were divided into two subtypes by consensus clustering of data from m6A RNA methylation regulators. The differences in PD-L1, immune infiltration, and prognosis between the two subtypes were further compared. The LASSO regression was used to build a risk score for m6A modulators. In addition, we identified miRNAs that regulate m6A regulators. Results. We found that fourteen m6A regulatory genes were significantly differentially expressed between HCC and normal. HCC samples were divided into two clusters. Of these, there are higher PD-L1 expression and poorer overall survival (OS) in cluster 1. There was a significant difference in immune cell infiltration between cluster 1 and cluster 2. Through the LASSO model, we obtained 12 m6A methylation regulators to construct a prognostic risk score. Compared with patients with a high-risk score, patients with a low-risk score had upregulated PD-L1 expression and worse prognosis. There was a significant correlation between risk score and tumor-infiltrating immune cells. Finally, we found that miR-142 may be the important regulator for m6A RNA methylation in HCC. Conclusion. Our results suggest that m6A RNA methylation modulators may affect the prognosis through PD-L1 and immune cell infiltration in HCC patients. In addition, the two clusters may be beneficial for prognostic stratification and improving immunotherapeutic efficacy.http://dx.doi.org/10.1155/2021/5516100 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yingxue Lin Yinhui Yao Ying Wang Lingdi Wang Haipeng Cui |
spellingShingle |
Yingxue Lin Yinhui Yao Ying Wang Lingdi Wang Haipeng Cui PD-L1 and Immune Infiltration of m6A RNA Methylation Regulators and Its miRNA Regulators in Hepatocellular Carcinoma BioMed Research International |
author_facet |
Yingxue Lin Yinhui Yao Ying Wang Lingdi Wang Haipeng Cui |
author_sort |
Yingxue Lin |
title |
PD-L1 and Immune Infiltration of m6A RNA Methylation Regulators and Its miRNA Regulators in Hepatocellular Carcinoma |
title_short |
PD-L1 and Immune Infiltration of m6A RNA Methylation Regulators and Its miRNA Regulators in Hepatocellular Carcinoma |
title_full |
PD-L1 and Immune Infiltration of m6A RNA Methylation Regulators and Its miRNA Regulators in Hepatocellular Carcinoma |
title_fullStr |
PD-L1 and Immune Infiltration of m6A RNA Methylation Regulators and Its miRNA Regulators in Hepatocellular Carcinoma |
title_full_unstemmed |
PD-L1 and Immune Infiltration of m6A RNA Methylation Regulators and Its miRNA Regulators in Hepatocellular Carcinoma |
title_sort |
pd-l1 and immune infiltration of m6a rna methylation regulators and its mirna regulators in hepatocellular carcinoma |
publisher |
Hindawi Limited |
series |
BioMed Research International |
issn |
2314-6141 |
publishDate |
2021-01-01 |
description |
Background. The aim of this study was to systematically evaluate the relationship between the expression of m6A RNA methylation regulators and prognosis in HCC. Methods. We compared the expression of m6A methylation modulators and PD-L1 between HCC and normal in TCGA database. HCC samples were divided into two subtypes by consensus clustering of data from m6A RNA methylation regulators. The differences in PD-L1, immune infiltration, and prognosis between the two subtypes were further compared. The LASSO regression was used to build a risk score for m6A modulators. In addition, we identified miRNAs that regulate m6A regulators. Results. We found that fourteen m6A regulatory genes were significantly differentially expressed between HCC and normal. HCC samples were divided into two clusters. Of these, there are higher PD-L1 expression and poorer overall survival (OS) in cluster 1. There was a significant difference in immune cell infiltration between cluster 1 and cluster 2. Through the LASSO model, we obtained 12 m6A methylation regulators to construct a prognostic risk score. Compared with patients with a high-risk score, patients with a low-risk score had upregulated PD-L1 expression and worse prognosis. There was a significant correlation between risk score and tumor-infiltrating immune cells. Finally, we found that miR-142 may be the important regulator for m6A RNA methylation in HCC. Conclusion. Our results suggest that m6A RNA methylation modulators may affect the prognosis through PD-L1 and immune cell infiltration in HCC patients. In addition, the two clusters may be beneficial for prognostic stratification and improving immunotherapeutic efficacy. |
url |
http://dx.doi.org/10.1155/2021/5516100 |
work_keys_str_mv |
AT yingxuelin pdl1andimmuneinfiltrationofm6arnamethylationregulatorsanditsmirnaregulatorsinhepatocellularcarcinoma AT yinhuiyao pdl1andimmuneinfiltrationofm6arnamethylationregulatorsanditsmirnaregulatorsinhepatocellularcarcinoma AT yingwang pdl1andimmuneinfiltrationofm6arnamethylationregulatorsanditsmirnaregulatorsinhepatocellularcarcinoma AT lingdiwang pdl1andimmuneinfiltrationofm6arnamethylationregulatorsanditsmirnaregulatorsinhepatocellularcarcinoma AT haipengcui pdl1andimmuneinfiltrationofm6arnamethylationregulatorsanditsmirnaregulatorsinhepatocellularcarcinoma |
_version_ |
1721419773405822976 |